Condensed interim consolidated statements of operations and comprehensive loss (USD $)	3 Months Ended		6 Months Ended
	Mar. 31, 2012	Mar. 31, 2011	Mar. 31, 2012	Mar. 31, 2011
Net revenues	$ 32,780,933	$ 46,710,589	$ 104,535,890	$ 110,240,808
Cost of revenues	(36,651,065)	(42,261,582)	(94,374,822)	(95,795,437)
Gross profit	(3,870,132)	4,449,007	10,161,068	14,445,371
Operating expenses:
Research and development expenses	(1,847,927)	(1,932,735)	(3,092,079)	(3,577,479)
Sales and marketing expenses	(1,752,896)	(2,198,785)	(3,710,566)	(4,472,148)
General and administrative expenses	(7,112,209)	(2,149,986)	(12,901,485)	(10,028,657)
Impairment charge			(2,707,686)	0
Total operating expenses	(10,713,032)	(6,281,506)	(22,411,816)	(18,078,284)
Operating loss	(14,583,164)	(1,832,499)	(12,250,748)	(3,632,913)
Finance costs, net	(2,634,429)	(2,512,322)	(5,517,158)	(5,351,962)
Government grant income	1,185,294	30,769	2,009,981	637,740
Other income	412,097	48,732	431,979	290,225
Loss before income taxes	(15,620,202)	(4,265,320)	(15,325,946)	(8,056,910)
Income tax benefits / (expenses)	(7,846)	181,760	(2,121,856)	315,558
Net loss	(15,628,048)	(4,083,560)	(17,447,802)	(7,741,352)
Other comprehensive income
- Foreign currency translation adjustment	67,744	1,228,458	1,858,831	3,278,610
Comprehensive loss	$ (15,560,304)	$ (2,855,102)	$ (15,588,971)	$ (4,462,742)
Net loss per share:
- Basic	$ (0.25)	$ (0.06)	$ (0.28)	$ (0.12)
- Diluted	$ (0.25)	$ (0.06)	$ (0.28)	$ (0.12)
Weighted average number of shares of common stock:
- Basic	63,095,246	62,895,246	63,095,246	62,895,122
- Diluted	63,095,246	62,895,246	63,095,246	62,895,122